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risk of mortality for platinum-based chemo-
therapy (the very unlikely scenario), the over-
all estimate would still significantly favor
chemotherapy.
In the past there have been many in-
stances in which the failure to adapt signifi-
cant advances in treatment has led to delays
in passing on the benefits to the patient in the
clinic. Examples include thrombolytic ther-
apy or beta-blocker therapy after myocardial
infarctions.7,8 These non–IPD-based system-
atic reviews highlighted that each year of
delay may cost thousands of lives worldwide
and were influential for the development of
evidence-based medicine. We believe that
delay in the case of postoperative chemother-
apy may have the same consequences and be
interpreted as reflecting clinician uncertainty
and potentially lead to the design and conduct
of further clinical trials in which the question
has been clearly answered.9,10 As Sir Austin
Bradford Hill pointed out in his presidential
address at the Royal Society of Medicine
(January 14, 1965), “All scientific work is
incomplete—whether it be observational or
experimental. It is liable to be upset or mod-
ified by advancing knowledge. That does not
confer upon us a freedom to ignore the
knowledge we already have, or to postpone
the action that appears to demand at a given
time.” In this regard the evidence is very
strong that adjuvant chemotherapy improves
patient survival postresection. Optimizing
therapy and targeting those patients most
likely to benefit from treatment are clinically
important questions that the IPD study may
address. Further trials in the already studied
population randomizing patients to a “no che-
motherapy” arm are, however, unlikely to
contribute to existing knowledge and are eth-
ically questionable.
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Single-stage repair of extensive
thoracic aortic aneurysms
To the Editor:
I congratulate Dr Kouchoukos and col-
leagues1 for their excellent results with the
single-stage repair technique of extended
thoracic aortic aneurysms. We originally
introduced this technique2 in 1994 with a
limited series of 16 patients and a hospital
mortality of 12.5%. Ten years ago axillary
artery cannulation, branched arterial grafts,
and antegrade cerebral perfusion were not
routinely used. As a consequence, cerebral
ischemia was longer than today, and pa-
tients had to undergo operation with deep
hypothermia and circulatory arrest. In our
first series cerebral ischemia averaged 55.7
minutes. A further consequence of deep
hypothermia was more frequent respiratory
complications than observed today. During
recent years, we also improved our tech-
nique by adding antegrade cerebral perfu-
sion, either through retrograde axillary ar-
tery perfusion or the “aortic arch (or
branch) first” technique, as suggested by
Dr Kouchoukos and colleagues.1 Body
temperature is generally decreased to no
more than 25°C. Our series now includes
approximately 53 patients with an overall
hospital mortality of 9.4%. Among the last
30 patients, hospital mortality was 6.7%;
neurologic and respiratory complications
accounted for 3.3% and 6.7%, respectively.
In regard to the “clamshell” access, we still
use an approach through a limited right
anterior thoracotomy through the third in-
tercostal space and an anterolateral left tho-
racotomy through the fourth intercostal
space with the patient banked 45 degrees
on the right side. In our opinion, this access
gives an easier approach to the aortic root
along with the arch branches and to the
most distal portion of the thoracic aorta.
Reimplantation of lower intercostal arteries
is not a problem in this way. Contrary to
some of Dr Kouchoukos discussants, I
fully agree with the author on the strategy
of the single-stage approach in complex
cases of thoracic aortic aneurysms. This
often is the case in patients who have un-
dergone operation for acute type A aortic
dissection, in whom the aortic valve had
been repaired and the ascending aorta had
been replaced by a tube graft, even though
it was extended in some cases to a proximal
hemiarch. In such acute instances, the Ben-
tall or equivalent techniques will not be
used universally, and the elephant-trunk
technique will be used even less. A com-
mon late observation in such cases is an-
eurysm development in the aortic root, of-
ten associated with valve incompetence,
and distal part of the arch and descending
aorta. Conventionally, the treatment of these
patients would include a repeat sternotomy
with Bentall or valve-sparing procedures,
arch replacement with the elephant-trunk
technique, and followed later by a second
procedure with replacement or endostenting
of the descending portion of the aorta when-
ever possible. Actually, endovascular stent-
ing of the descending aorta is not always a
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guarantee against secondary disruption or
leakage. Except for the discomfort experi-
enced by the patients, the cumulative risk
for the multiple-stage approach can reason-
ably be presumed to be higher than that
reported by Dr Kouchoukos et al and our-
selves for the single-stage approach. For
these reasons I strongly recommend Dr
Kouchoukos and colleagues’ suggestions
to trust the single-stage techniques in se-
lected cases whenever indicated.
Carmine Minale, MD
Cardiovascular Department
Division of Cardiovascular Surgery
Ospedale San Carlo
Potenza, Italy
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Reply to the Editor:
My coauthors and I are indebted to Dr
Minale and colleagues for reporting their
initial experience with the single-stage
technique for extensive thoracic aortic re-
sections in 1994,1 which stimulated us to
use and evaluate it in our surgical practice.
We also appreciate the update of their ex-
perience with this technique, which indi-
cates outcomes very similar to those that
we have reported.2 We prefer, however, to
cool to systemic temperatures lower than
25°C to provide additional protection in the
event that the ischemic intervals for the
brain and spinal cord are prolonged beyond
the usual safe intervals. We do not believe
that the lower temperatures are associated
with increased morbidity. We have found
that an incision through the fourth intercos-
tal space bilaterally provides excellent ex-
posure of the aortic root, entire aortic arch,
interatrial groove, and most distal portion
of the descending thoracic aorta.
We agree with Dr Minale that the sin-
gle-stage technique is of particular value in
patients who require reoperation after pre-
vious repair of an acute type A aortic dis-
section or who have a type A dissection
after previous coronary artery or valve sur-
gery. Chronic type A dissection was the
indication for use of the single-stage pro-
cedure in 30 of the 46 patients in our series,
and the procedure remains our technique of
choice in this setting.2 It permits, as Dr
Minale has emphasized, easy access to
both the aortic root and the distal descend-
ing thoracic aorta.
Nicholas T. Kouchoukos, MD
Cardiac, Thoracic and Vascular Surgery Inc
St Louis, MO 63131
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Total aortic arch replacement and
limited circulatory arrest of the brain
To the Editor:
We read with great interest the article by
Kouchoukos and Masetti1 titled “Total
Aortic Arch Replacement With a Branched
Graft and Limited Circulatory Arrest of the
Brain,” published in the August 2004 issue
of the Journal. The article describes the
authors’ experience with total arch replace-
ment (TAR) for various pathologic condi-
tions of the aortic arch (except acute type A
dissection) with branched aortic prostheses
and unilateral antegrade cerebral perfusion
through the right axillary artery. The article
generally attests to the appropriateness of
the use of branched aortic prosthesis and
antegrade brain perfusion for TAR surgery.
Since 1986, we have been routinely using
antegrade selective cerebral perfusion and
a branched aortic graft for TAR proce-
dures.2 The results we have achieved
through the years give us reason to be
convinced that the use of the branched
grafts rather than tube prostheses and ante-
grade brain perfusion for cerebral protection
represent the optimum surgical strategy for
this complex surgery.3 The branched aortic
graft allows easier bleeding control at arch-
vessel anastomotic sites and has been
found to be associated with a lower inci-
dence of postoperative strokes, making it a
better option than tube graft. Similarly, se-
lective cerebral perfusion, when used to its
full potential, basically relieves the surgeon
from the psychologic burden of a limited
brain protection time and thus allows me-
ticulous arch repair. It is good to see that
more and more aortic surgeons all over the
world are realizing the advantages of these
techniques, which once were thought to be
cumbersome.
Concerns have been expressed by
some authorities, including Kouchoukos
and Masetti,1 regarding the potential haz-
ards of direct cannulation of the arch ves-
sels in the form of cerebral embolization of
air or debris. In our experience, such con-
cerns are mostly unwarranted. Our arch
vessel cannulation technique involves tran-
secting the arch vessels distant from their
origins, at sites where they are free from
atherosclerotic debris or dissection, and
then cannulating them under direct vision.
Blood flow through the arch vessels is con-
tinued until just before the cannulation with
the patient in a Trendelenburg position.
These measures help to avoid air embo-
lism.4
For patients with acute type A aortic
dissection and degenerative arch aneurysm
requiring TAR in whom the ascending
aorta is not suitable for arterial inflow be-
cause of atheromas, we first cannulate the
right axillary artery through an 8-mm graft
attached to it in an end-to-side fashion.
Then, after cooling of the patient with car-
diopulmonary bypass and initiation of cir-
culatory arrest, the left common carotid
artery is also cannulated, ensuring bihemi-
spheric antegrade brain perfusion during
the arch repair. Although some authors
have advocated the use of unilateral cere-
bral perfusion for aortic arch replacement
surgery,5 our experience with that tech-
nique is limited to cases requiring a less
radical aortic repair, such as ascending aor-
tic replacement with open distal anastomo-
sis or hemiarch replacement. In 10 patients
(acute type A dissection n  7, chronic
type A dissection n  1, degenerative arch
aneurysm n  1, and mycotic arch aneu-
rysm n  1), hemiarch replacement was
carried out with right axillary artery perfu-
sion as the only brain protection method
under moderate hypothermic circulatory
arrest (mean rectal and tympanic tempera-
tures 22.3°C  1.6°C and 16.9°C  2.4°C,
respectively). Mean perfusion flow rate and
pressure were 5.1  1.9 mL/(kg · min) and
27.8  9.4 mm Hg, respectively. Mean
selective cerebral perfusion time was 35.8
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